Esperion Therapeutics, Inc. (ESPR)
2.77
-0.14
(-4.81%)
USD |
NASDAQ |
Mar 05, 16:00
2.79
+0.02
(+0.72%)
After-Hours: 20:00
Esperion Therapeutics Free Cash Flow : -93.29M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Nektar Therapeutics | -190.35M |
| Rigel Pharmaceuticals, Inc. | 75.66M |
| Harrow, Inc. | 42.76M |
| AnaptysBio, Inc. | 19.61M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.286M |
| Cash from Financing (Quarterly) | 10.67M |
| Free Cash Flow Per Share (Quarterly) | -0.0214 |
| Free Cash Flow to Equity (Quarterly) | -7.093M |
| Free Cash Flow to Firm (Quarterly) | 17.76M |
| Free Cash Flow Yield | -17.05% |